搜索筛选:
搜索耗时3.3985秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
Alendronate versus raloxifene for postmenopausal osteoporosis: a pooled analysis of seven head-to-he
[会议论文] 作者：林调;蔡迅梓;应志敏;袁福贞;严世贵;,
来源：第九届中国南方骨质疏松论坛暨江西省骨质疏松学术会 年份：2013
Objective: To perform a meta-analysis exclusively including head-to-head randomized controlled trials (RCTs) that directly compared the fracture prevention...
Alendronate versus raloxifene for postmenopausal osteoporosis: a pooled analysis of seven head-to-he
[会议论文] 作者：林调,蔡迅梓,应志敏,袁福贞,严世贵,
来源：第九届中国南方骨质疏松论坛暨江西省骨质疏松学术会 年份：2013
Objective: To perform a meta-analysis exclusively including head-to-head randomized controlled trials (RCTs) that directly compared the fracture prevention efficacy and the safety between alendronate...
[会议论文] 作者：林调, 王聪, 蔡迅梓, 赵翔, 史明敏, 应志敏, 袁福贞,
来源： 年份：2004
Objective:The aim of this study was to perform a head-to-head comparison of efficacy and safety profile between 60 mg denosumab(Den) subcutaneously(SC) per...
Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women
[会议论文] 作者：林调;王聪;蔡迅梓;赵翔;史明敏;应志敏;袁福贞;郭超;严世贵;,
来源：第九届中国南方骨质疏松论坛暨江西省骨质疏松学术会 年份：2013
The aim of this study was to perform a head-to-head comparison of efficacy and safety profile between 60 mg denosumab (Den) subcutaneously (SC) per 6 months...
Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women
[会议论文] 作者：林调,王聪,蔡迅梓,赵翔,史明敏,应志敏,袁福贞,郭超,严世贵,
来源：第九届中国南方骨质疏松论坛暨江西省骨质疏松学术会 年份：2013
The aim of this study was to perform a head-to-head comparison of efficacy and safety profile between 60 mg denosumab (Den) subcutaneously (SC) per 6 months (Q6M) and 70 mg alendronate (Aln) orally pe...
相关搜索：
